Cook Pharmica teams with cell line development firm Selexis
Cook Pharmica and Selexis claim their combined service offering will help biopharmas scale up mAb and biosimilars production faster and more cheaply.
Cook Pharmica and Selexis claim their combined service offering will help biopharmas scale up mAb and biosimilars production faster and more cheaply.
European biopharmas trying to avoid “death valley” went to California this week according to industry groups, investors and officials who met in Belgium this week to discuss ways of making it easier for companies to access funding on this side of the...
Fujifilm Diosynth Biotechnologies has expanded process development capacity at its site in the UK with a new $5.6m investment and a TAP bioreactor.